| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f3bfa1ea23811691383537e2a571aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38bc839a634e0b758ce343c2295b2c5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7506dd9e80ab17647fec456aeec02a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c444ff65bca51e2fce11e37a2e0ca3d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d91fc67a8225d1a0f139fffe5e7895fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-90 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e959040d9c6ecfc604206adf065401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd7aceb5512f486c3de30df1c41cdc2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3808113187dfb15f2ec21f48121a12e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b1fd16d89ec3848effc539e9dcb97c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7e87be2d70171bb0be0bb8c925bd07f |
| publicationDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017015442-A1 |
| titleOfInvention |
Combination of immunomodulatory agent with pd-1-or pd-l1 checkpoint inhibitors in the treatment of cancer |
| abstract |
Methods for treating cancer include administering a therapeutically effective amount of an immunomodulatory agent such as interferon gamma 1b in combination with a therapeutically effective amount of a PD-1 checkpoint inhibitor such as nivolumab or pembrolizumab or a therapeutically effective amount of a PD-L1 checkpoint inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019055860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654135-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020525434-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109503718-A |
| priorityDate |
2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |